These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22612699)

  • 1. Integrin-mediated drug delivery in cancer and cardiovascular diseases with peptide-functionalized nanoparticles.
    Arosio D; Casagrande C; Manzoni L
    Curr Med Chem; 2012; 19(19):3128-51. PubMed ID: 22612699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating angiogenesis with integrin-targeted nanomedicines.
    Duro-Castano A; Gallon E; Decker C; Vicent MJ
    Adv Drug Deliv Rev; 2017 Sep; 119():101-119. PubMed ID: 28502767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.
    Meyer A; Auernheimer J; Modlinger A; Kessler H
    Curr Pharm Des; 2006; 12(22):2723-47. PubMed ID: 16918408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancement in integrin facilitated drug delivery.
    Arosio D; Casagrande C
    Adv Drug Deliv Rev; 2016 Feb; 97():111-43. PubMed ID: 26686830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin targeted drug and gene delivery.
    Wang Z; Chui WK; Ho PC
    Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha v integrin inhibitors and cancer therapy.
    Tucker GC
    Curr Opin Investig Drugs; 2003 Jun; 4(6):722-31. PubMed ID: 12901232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
    Yu MK; Park J; Jeong YY; Moon WK; Jon S
    Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrins as therapeutic targets: lessons and opportunities.
    Cox D; Brennan M; Moran N
    Nat Rev Drug Discov; 2010 Oct; 9(10):804-20. PubMed ID: 20885411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides.
    Egorova EA; Nikitin MP
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of integrins.
    Tucker GC
    Curr Opin Pharmacol; 2002 Aug; 2(4):394-402. PubMed ID: 12127872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active drug targeting of disease by nanoparticles functionalized with ligand to folate receptor.
    Tu Q; Zhang Y; Liu R; Wang JC; Li L; Nie N; Liu A; Wang L; Liu W; Ren L; Wang X; Wang J
    Curr Med Chem; 2012; 19(19):3152-62. PubMed ID: 22612700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.
    Paulhe F; Manenti S; Ysebaert L; Betous R; Sultan P; Racaud-Sultan C
    Curr Pharm Des; 2005; 11(16):2119-34. PubMed ID: 15974963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting integrins for the control of tumour angiogenesis.
    Akalu A; Cretu A; Brooks PC
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1475-86. PubMed ID: 16307488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.